Fraser Cunningham

Fraser Cunningham has a diverse work experience in the pharmaceutical and academic sectors. Fraser is currently working as an Associate Director, Drug Design at Exscientia since October 2023. Prior to that, they served as a Senior Portfolio Manager at Exscientia from February 2022 to October 2023.

Before joining Exscientia, Fraser worked at the University of Dundee from September 2019 to January 2022. During their time there, they held the position of Coronavirus Portfolio Leader from March 2021 to January 2022. Fraser also served as a Medicinal Chemistry Team Leader, leading a team of 7 chemists working on key programs in CNS disease, and as a project leader for two fully resourced projects with additional responsibility for 5 FTEs.

Prior to their role at the University of Dundee, Fraser worked at GSK from March 2013 to September 2019. At GSK, they held various positions including Lead Chemist from October 2016 to September 2019, Senior Scientist from March 2014 to October 2016, and Marie Curie postdoctoral fellow from March 2013 to March 2014. Fraser contributed to drug development programs and acted as a mentor to PhD students and Open Lab students.

Earlier in their career, Fraser was a PhD Research Student at the University of Leeds from October 2009 to March 2013. Fraser also worked as a Summer Project Student at Heriot-Watt University from July 2008 to September 2008, where they were involved in the development of composite membranes for methanol fuel cells under the supervision of Dr. Shanwen Tao.

Overall, Fraser Cunningham has gained significant expertise and leadership experience in drug design, portfolio management, chemistry, and research throughout their career in both industry and academia.

Fraser Cunningham completed their education at the University of Leeds from 2009 to 2013, earning a Doctor of Philosophy (PhD) in Medicinal Chemistry. Prior to that, they attended Heriot-Watt University from 2004 to 2009, where they pursued a degree in Chemistry with Pharmaceutical Chemistry, focusing on Chemistry and Medicinal Chemistry.